Cargando…

The Controversial Role of Autophagy in Ewing Sarcoma Pathogenesis—Current Treatment Options

Ewing Sarcoma (ES) is a rare, aggressive, and highly metastasizing cancer in children and young adults. Most ES cases carry the fusion of the Ewing Sarcoma Breakpoint Region 1 (EWSR1) and FLI1 (Friend leukemia virus integration site 1) genes, leading to an EWS–FLI1 fused protein, which is associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koustas, Evangelos, Sarantis, Panagiotis, Karamouzis, Michalis V., Vielh, Philippe, Theocharis, Stamatios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996923/ https://www.ncbi.nlm.nih.gov/pubmed/33652741 http://dx.doi.org/10.3390/biom11030355

Ejemplares similares

Upgraded role of autophagy in colorectal carcinomas
por: Koustas, Evangelos, et al.
Publicado: (2018)

Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy
por: Koustas, Evangelos, et al.
Publicado: (2021)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021)

HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment
por: Papatheofani, Vasiliki, et al.
Publicado: (2021)

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
por: Koustas, Evangelos, et al.
Publicado: (2019)

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Inhibition of c‐MET increases the antitumour activity of PARP inhibitors in gastric cancer models
por: Koustas, Evangelos, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer
por: Koustas, Evangelos, et al.
Publicado: (2019)

Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
por: Koustas, Evangelos, et al.
Publicado: (2022)

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status
por: Koustas, Evangelos, et al.
Publicado: (2018)

The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches
por: Koustas, Evangelos, et al.
Publicado: (2022)

Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment
por: Shalit, Almog, et al.
Publicado: (2023)

The Implication of Autophagy in Gastric Cancer Progression
por: Koustas, Evangelos, et al.
Publicado: (2021)

Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment
por: Koustas, Evangelos, et al.
Publicado: (2023)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2020)

Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
por: Poulia, Kalliopi Anna, et al.
Publicado: (2020)

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas
por: Zoi, Ilianna, et al.
Publicado: (2019)

An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2021)

An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches
por: Koustas, Evangelos, et al.
Publicado: (2023)

Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway
por: Siatis, Konstantinos E., et al.
Publicado: (2023)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
por: Garmpis, Nikolaos, et al.
Publicado: (2021)

Current Status of Management and Outcome for Patients with Ewing Sarcoma
por: Hesla, Asle Charles, et al.
Publicado: (2021)

Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
por: Kowalewski, Ashley A., et al.
Publicado: (2011)

Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment
por: Skandalaki, Aikaterini, et al.
Publicado: (2021)

Pancreatic Cancer Prognosis, Malnutrition Risk, and Quality of Life: A Cross-Sectional Study
por: Poulia, Kalliopi-Anna, et al.
Publicado: (2022)

Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options
por: Manou, Maria, et al.
Publicado: (2023)

Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis
por: Aryee, Dave N. T., et al.
Publicado: (2022)

Current questions and possible controversies in autophagy
por: Lindqvist, L M, et al.
Publicado: (2015)

Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity
por: Ullah, Asad, et al.
Publicado: (2021)

The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
por: Damaskos, Christos, et al.
Publicado: (2022)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours
por: Kelleher, Fergal C, et al.
Publicado: (2012)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rcfqcgfblc5ap1uaqcb0unfq8c